BRCA2 and neoplasm: We first assessed the effect of ART558, alone and in combination with IR, in three tumor cell lines that do not harbor mutations in BRCA-1 or BRCA-2 genes (27): HCT116 (colorectal), H460 (lung), and T24 (bladder).